364 related articles for article (PubMed ID: 24477414)
1. Regulatory mechanisms of RANKL presentation to osteoclast precursors.
Honma M; Ikebuchi Y; Kariya Y; Suzuki H
Curr Osteoporos Rep; 2014 Mar; 12(1):115-20. PubMed ID: 24477414
[TBL] [Abstract][Full Text] [Related]
2. Osteoclast differentiation by RANKL and OPG signaling pathways.
Udagawa N; Koide M; Nakamura M; Nakamichi Y; Yamashita T; Uehara S; Kobayashi Y; Furuya Y; Yasuda H; Fukuda C; Tsuda E
J Bone Miner Metab; 2021 Jan; 39(1):19-26. PubMed ID: 33079279
[TBL] [Abstract][Full Text] [Related]
3. RANKL subcellular trafficking and regulatory mechanisms in osteocytes.
Honma M; Ikebuchi Y; Kariya Y; Hayashi M; Hayashi N; Aoki S; Suzuki H
J Bone Miner Res; 2013 Sep; 28(9):1936-49. PubMed ID: 23529793
[TBL] [Abstract][Full Text] [Related]
4. CCN2 enhances RANKL-induced osteoclast differentiation via direct binding to RANK and OPG.
Aoyama E; Kubota S; Khattab HM; Nishida T; Takigawa M
Bone; 2015 Apr; 73():242-8. PubMed ID: 25554597
[TBL] [Abstract][Full Text] [Related]
5. MLO-Y4 osteocyte-like cells support osteoclast formation and activation.
Zhao S; Zhang YK; Harris S; Ahuja SS; Bonewald LF
J Bone Miner Res; 2002 Nov; 17(11):2068-79. PubMed ID: 12412815
[TBL] [Abstract][Full Text] [Related]
6. Apoptotic osteocytes regulate osteoclast precursor recruitment and differentiation in vitro.
Al-Dujaili SA; Lau E; Al-Dujaili H; Tsang K; Guenther A; You L
J Cell Biochem; 2011 Sep; 112(9):2412-23. PubMed ID: 21538477
[TBL] [Abstract][Full Text] [Related]
7. Functions of RANKL/RANK/OPG in bone modeling and remodeling.
Boyce BF; Xing L
Arch Biochem Biophys; 2008 May; 473(2):139-46. PubMed ID: 18395508
[TBL] [Abstract][Full Text] [Related]
8. Local Production of Osteoprotegerin by Osteoblasts Suppresses Bone Resorption.
Cawley KM; Bustamante-Gomez NC; Guha AG; MacLeod RS; Xiong J; Gubrij I; Liu Y; Mulkey R; Palmieri M; Thostenson JD; Goellner JJ; O'Brien CA
Cell Rep; 2020 Sep; 32(10):108052. PubMed ID: 32905775
[TBL] [Abstract][Full Text] [Related]
9. IL-6 Enhances Osteocyte-Mediated Osteoclastogenesis by Promoting JAK2 and RANKL Activity In Vitro.
Wu Q; Zhou X; Huang D; Ji Y; Kang F
Cell Physiol Biochem; 2017; 41(4):1360-1369. PubMed ID: 28278513
[TBL] [Abstract][Full Text] [Related]
10. [Control of bone resorption by RANKL-RANK system].
Harada S; Takahashi N
Clin Calcium; 2011 Aug; 21(8):1121-30. PubMed ID: 21814016
[TBL] [Abstract][Full Text] [Related]
11. Iron Overload-Induced Osteocyte Apoptosis Stimulates Osteoclast Differentiation Through Increasing Osteocytic RANKL Production In Vitro.
Yang J; Dong D; Luo X; Zhou J; Shang P; Zhang H
Calcif Tissue Int; 2020 Nov; 107(5):499-509. PubMed ID: 32995951
[TBL] [Abstract][Full Text] [Related]
12. Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations.
Kennedy OD; Herman BC; Laudier DM; Majeska RJ; Sun HB; Schaffler MB
Bone; 2012 May; 50(5):1115-22. PubMed ID: 22342796
[TBL] [Abstract][Full Text] [Related]
13. Osteocytes produce interferon-β as a negative regulator of osteoclastogenesis.
Hayashida C; Ito J; Nakayachi M; Okayasu M; Ohyama Y; Hakeda Y; Sato T
J Biol Chem; 2014 Apr; 289(16):11545-11555. PubMed ID: 24610813
[TBL] [Abstract][Full Text] [Related]
14. Osteocyte-Related Cytokines Regulate Osteoclast Formation and Bone Resorption.
Kitaura H; Marahleh A; Ohori F; Noguchi T; Shen WR; Qi J; Nara Y; Pramusita A; Kinjo R; Mizoguchi I
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708317
[TBL] [Abstract][Full Text] [Related]
15. Tartrate-resistant acid phosphatase (TRAP) co-localizes with receptor activator of NF-KB ligand (RANKL) and osteoprotegerin (OPG) in lysosomal-associated membrane protein 1 (LAMP1)-positive vesicles in rat osteoblasts and osteocytes.
Solberg LB; Stang E; Brorson SH; Andersson G; Reinholt FP
Histochem Cell Biol; 2015 Feb; 143(2):195-207. PubMed ID: 25201349
[TBL] [Abstract][Full Text] [Related]
16. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of RANKL delivery to the osteoclast precursor cell surface.
Honma M; Ikebuchi Y; Suzuki H
J Bone Miner Metab; 2021 Jan; 39(1):27-33. PubMed ID: 33047191
[TBL] [Abstract][Full Text] [Related]
18. Osteocytes, not Osteoblasts or Lining Cells, are the Main Source of the RANKL Required for Osteoclast Formation in Remodeling Bone.
Xiong J; Piemontese M; Onal M; Campbell J; Goellner JJ; Dusevich V; Bonewald L; Manolagas SC; O'Brien CA
PLoS One; 2015; 10(9):e0138189. PubMed ID: 26393791
[TBL] [Abstract][Full Text] [Related]
19. High mobility group box 1 protein regulates osteoclastogenesis through direct actions on osteocytes and osteoclasts in vitro.
Davis HM; Valdez S; Gomez L; Malicky P; White FA; Subler MA; Windle JJ; Bidwell JP; Bruzzaniti A; Plotkin LI
J Cell Biochem; 2019 Oct; 120(10):16741-16749. PubMed ID: 31106449
[TBL] [Abstract][Full Text] [Related]
20. Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice.
Piemontese M; Xiong J; Fujiwara Y; Thostenson JD; O'Brien CA
Am J Physiol Endocrinol Metab; 2016 Sep; 311(3):E587-93. PubMed ID: 27460899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]